November, 2018

Companies that have the best reputation as innovators aren’t necessarily those that spend the most on R&D

November 9th, 2018

Despite Switzerland being known as one of the most innovative nations, latest reports have shown a 10% decline in the country’s research and development spending. This comes as a surprise due to the fact that worldwide R&D expenditure has reached an all-time high of $782 billion. The biggest Swiss companies invested $27.5 billion into R&D in 2018. The majority of the decline has come from Basel-based giant pharmaceutical companies Roche and Novartis. Roche spent around $1 billion less on R&D […]

Read More

Government commitment to pioneer in the life sciences industry by investing into research and development

November 7th, 2018

In 2016 the Johnson & Johnson Partnering Office was launched to enable innovative research and development (R&D) for Queensland’s life sciences industry. The R&D facility is housed at Queensland University of Technology’s (QUT) Institute of Health and Biomedical Innovation. The R&D centre serves as a strong platform to identify and nurture life science and research collaborations. Following on from the launch in 2016, the Queensland government has now announced a significant extension of the Johnson & Johnston R&D Office at […]

Read More

Cosmetic brand Cellmid Limited has received an $808,000 research and development grant

November 1st, 2018

The functional cosmetics brand, Cellmid Limited has received an $808,000 research and development grant under the tax incentive scheme from the Australian Taxation Office. Cellmid is an Australian life sciences accelerator with lead programs in multiple disease indications. The company holds the largest and most comprehensive portfolio of intellectual property relating to the novel targets midkine (MK) and FGF5, which are growth promoting protein supplements and products. After Cellmid generated $5.64 million in revenue for FY18 and continues to rapidly […]

Read More

Email this job